California Nanotechnologies Corp Cash Flow Conversion Efficiency
California Nanotechnologies Corp cash flow conversion efficiency. Based on the latest financial reports, California Nanotechnologies Corp (CNO) has a cash flow conversion efficiency ratio of -0.223x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-521.56K ≈ $-377.29K USD) by net assets (CA$2.34 Million ≈ $1.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of California Nanotechnologies Corp (2014–2026)
Cash flow conversion efficiency of California Nanotechnologies Corp from 2014 to 2026. This chart illustrates how California Nanotechnologies Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest California Nanotechnologies Corp stock price today for real-time trading data and today's change.
California Nanotechnologies Corp Cash Flow Conversion Ratio Explained
California Nanotechnologies Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
California Nanotechnologies Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of California Nanotechnologies Corp ranked by their cash flow conversion efficiency. Also see CNO market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Iconovo
ST:ICO
|
-0.057x |
|
Leaders Cosmetics Co. Ltd
KQ:016100
|
0.006x |
|
Taihan Textile
KO:001070
|
-0.044x |
|
Bumi Benowo Sukses Sejahtera Pt
JK:BBSS
|
-0.003x |
|
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
|
-1.116x |
|
SBC Corp Bhd
KLSE:5207
|
0.012x |
|
Audalia Resources Ltd
AU:ACP
|
-0.027x |
|
Berkah Beton Sadaya Tbk PT
JK:BEBS
|
0.001x |
Annual Cash Flow Conversion Efficiency for California Nanotechnologies Corp (2014–2026)
The table below shows the annual cash flow conversion efficiency of California Nanotechnologies Corp from 2014 to 2026. Review CNO free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-02-28 | CA$1.98 Million ≈ $1.43 Million |
CA$-382.17K ≈ $-276.46K |
-0.193x | -115.30% |
| 2025-02-28 | CA$2.32 Million ≈ $1.68 Million |
CA$2.92 Million ≈ $2.12 Million |
1.262x | +76.69% |
| 2024-02-29 | CA$145.97K ≈ $105.59K |
CA$104.28K ≈ $75.44K |
0.714x | +228.48% |
| 2023-02-28 | CA$-1.29 Million ≈ $-932.80K |
CA$717.01K ≈ $518.68K |
-0.556x | -1276.91% |
| 2022-02-28 | CA$-1.36 Million ≈ $-984.64K |
CA$54.97K ≈ $39.76K |
-0.040x | -101.41% |
| 2021-02-28 | CA$-1.66 Million ≈ $-1.20 Million |
CA$33.20K ≈ $24.02K |
-0.020x | +82.13% |
| 2020-02-29 | CA$-1.61 Million ≈ $-1.16 Million |
CA$180.62K ≈ $130.66K |
-0.112x | -41.48% |
| 2019-02-28 | CA$-1.54 Million ≈ $-1.11 Million |
CA$122.23K ≈ $88.42K |
-0.079x | -141.84% |
| 2018-02-28 | CA$-1.44 Million ≈ $-1.04 Million |
CA$47.31K ≈ $34.23K |
-0.033x | -118.62% |
| 2017-02-28 | CA$-1.47 Million ≈ $-1.07 Million |
CA$-259.79K ≈ $-187.93K |
0.176x | +15.63% |
| 2016-02-29 | CA$-875.61K ≈ $-633.40K |
CA$-133.41K ≈ $-96.50K |
0.152x | -56.71% |
| 2015-02-28 | CA$-724.52K ≈ $-524.11K |
CA$-254.97K ≈ $-184.44K |
0.352x | +23.37% |
| 2014-02-28 | CA$-939.23K ≈ $-679.43K |
CA$-267.92K ≈ $-193.81K |
0.285x | -- |
About California Nanotechnologies Corp
California Nanotechnologies Corp. engages in the research, development, and production of nanocrystalline materials through grain size reduction in the United States. The company offers sintering, bonding, and hot isostatic pressing services, including spark plasma/field assisted sintering, hot pressing/direct hot pressing, high temp sintering, diffusion bonding, and vacuum/pressure-less sinterin… Read more